While discounted playing cards can help reduce the load of significant drug costs while in the short-term, they don't tackle the systemic troubles driving up prescription costs in the U.S. Broader policy adjustments could tackle the basis leads to of mounting drug prices, such as deficiency of transparency in pricing as well as purpose of intermedi